Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for InMode Ltd. (INMD:NASDAQ), powered by AI.
InMode Ltd. is currently trading at $13.49. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for InMode Ltd. on Alpha Lenz.
InMode Ltd.'s P/E ratio is 9.3.
“InMode Ltd. trades at a P/E of 9.3 (undervalued) with solid ROE of 13.5%. Operating margin of 23.0% indicates strong profitability.”
Ask for details →InMode Ltd. is a leading global provider of innovative medical technologies focused on the aesthetic and wellness sectors. The company's primary function is to design and manufacture minimally invasive aesthetic healthcare solutions, leveraging advanced radiofrequency, light, and laser technologies. These products are widely used in procedures such as facial and body contouring, skin rejuvenation, and women’s health, among others. InMode's cutting-edge technology caters to the growing demand for aesthetic healthcare solutions that require minimal downtime and deliver effective results, impacting industries such as cosmetic surgery, dermatology, and gynecology. The company, founded in Israel, has expanded its reach globally, providing its solutions to clinics and practitioners in various regions. As a key player in the aesthetic medical device industry, InMode Ltd. plays a crucial role in advancing non-invasive treatment options, enabling practitioners to meet diverse patient needs while driving growth and innovation in the aesthetic healthcare market.
“InMode Ltd. trades at a P/E of 9.3 (undervalued) with solid ROE of 13.5%. Operating margin of 23.0% indicates strong profitability.”
Ask for details →InMode Ltd. (ticker: INMD) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 599 employees. Market cap is $872M.
The current price is $13.49 with a P/E ratio of 9.29x and P/B of 1.28x.
ROE is 13.53% and operating margin is 23.05%. Annual revenue is $370M.